Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

<p>Original picture</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Xiaodong Shu (16721586) (author)
Diğer Yazarlar:	Jianjie Li (16721589) (author), Un In Chan (16721592) (author), Sek Man Su (16721595) (author), Changxiang Shi (16721598) (author), Xin Zhang (16721601) (author), Tingting An (16721604) (author), Jun Xu (16721607) (author), Lihua Mo (16721610) (author), Jianlin Liu (16721613) (author), Yuqing Wang (16721616) (author), Xiaoling Li (16721619) (author), Min Deng (16721622) (author), Josh Haipeng Lei (16721625) (author), Chunfei Wang (16721628) (author), Hao Tian (16721631) (author), Sun Heng (16721634) (author), Joong Sup Shim (16721637) (author), Xuanjun Zhang (16721640) (author), Yunlu Dai (16721643) (author), Zhicheng Yao (16721646) (author), Xiaying Kuang (16721649) (author), Ying Lin (15293140) (author), Chu-Xia Deng (16721652) (author), Xiaoling Xu (16721655) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Biology Tumor Biology Immuno-oncology Breast Cancer Immunology Immunotherapy Checkpoint blockade Oncogenes & Tumor Suppressors Progression, Invasion & Metastasis Tumor Microenvironment
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
Yazar:: Xiaodong Shu (16721586)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Yazar:: Christine Pich-Bavastro (16509238)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
Yazar:: Kankan Cao (16437263)
Baskı/Yayın Bilgisi: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Yazar:: Sung-Eun Lee (14855067)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Yazar:: Aleksandar Obradovic (7549517)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Yazar:: Aleksandar Obradovic (7549517)
Baskı/Yayın Bilgisi: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
Yazar:: Ruiyun Zhang (17142498)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Yazar:: Clare Vesely (505402)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figures from NKG7 Is Required for Optimal Antitumor T-cell Immunity
Yazar:: Xian-Yang Li (15022958)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Yazar:: Arianna Draghi (15126339)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Yazar:: Arianna Draghi (15126339)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Yazar:: Arianna Draghi (15126339)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
Yazar:: Renumathy Dhanasekaran (14962092)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Yazar:: Sonia A. Patel (15055688)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Yazar:: Sonia A. Patel (15055688)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Yazar:: Sonia A. Patel (15055688)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Yazar:: Sonia A. Patel (15055688)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Yazar:: Sonia A. Patel (15055688)
Baskı/Yayın Bilgisi: (2025)

Supplementary video 1 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
Yazar:: Alvaro Teijeira (14962650)
Baskı/Yayın Bilgisi: (2025)

Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
Yazar:: Alvaro Teijeira (14962650)
Baskı/Yayın Bilgisi: (2025)

Supplementary video 3 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
Yazar:: Alvaro Teijeira (14962650)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ivnjuuk5al75lrds85q9rp1egh